3.2. Response of Patient-Derived Glioblastoma Cells and Normal Astrocytes to VPA Inhibitor Used Alone or in Combination with Alkylating Agent and PARP1 Inhibitor. The gene discussed is PARP1; the disease is glioblastoma.